Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Fassbender

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Current Biology : CB|March 19, 2004
Differences in DNA methylation patterns between humans and chimpanzeesWolfgang Enard, Anne Fassbender, Fabian Model, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 3, 2009
Quantitative DNA methylation profiling on a high-density oligonucleotide microarrayAnne Fassbender, Jörn Lewin, Thomas König, et al.
BMC Cancer|June 3, 2010
CDO1 promoter methylation is a biomarker for outcome prediction of anthracycline treated, estrogen receptor-positive, lymph node-positive breast cancer patientsDimo Dietrich, Manuel Krispin, Jörn Dietrich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
DNA methylation markers predict outcome in node-positive, estrogen receptor-positive breast cancer with adjuvant anthracycline-based chemotherapyOliver Hartmann, Frédérique Spyratos, Nadia Harbeck, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Current Biology : CB|March 19, 2004
Differences in DNA methylation patterns between humans and chimpanzeesWolfgang Enard, Anne Fassbender, Fabian Model, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 3, 2009
Quantitative DNA methylation profiling on a high-density oligonucleotide microarrayAnne Fassbender, Jörn Lewin, Thomas König, et al.
BMC Cancer|June 3, 2010
CDO1 promoter methylation is a biomarker for outcome prediction of anthracycline treated, estrogen receptor-positive, lymph node-positive breast cancer patientsDimo Dietrich, Manuel Krispin, Jörn Dietrich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
DNA methylation markers predict outcome in node-positive, estrogen receptor-positive breast cancer with adjuvant anthracycline-based chemotherapyOliver Hartmann, Frédérique Spyratos, Nadia Harbeck, et al.
Pageof 1